Does the media prefer TSTL or AMS?

In the previous week, Tristel had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for Tristel and 1 mentions for Advanced Medical Solutions Group. Tristel's average media sentiment score of 0.80 beat Advanced Medical Solutions Group's score of 0.44 indicating that Tristel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tristel 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Advanced Medical Solutions Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer TSTL or SPEC?

INSPECS Group has a consensus price target of GBX 60, indicating a potential downside of 38.14%. Given INSPECS Group's stronger consensus rating and higher probable upside, analysts clearly believe INSPECS Group is more favorable than Tristel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tristel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 INSPECS Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Is TSTL or SPEC more profitable?

Tristel has a net margin of 15.88% compared to INSPECS Group's net margin of -2.67%. Tristel's return on equity of 23.64% beat INSPECS Group's return on equity. Company Net Margins Return on Equity Return on Assets Tristel 15.88% 23.64% 9.89% INSPECS Group -2.67% -6.07% 0.45%

Tristel (TSTL) Competitors

GBX 426 0.00 (0.00%)

As of 07/31/2026 12:33 PM Eastern

Compare

TSTL vs. AMS, SPEC, BVC, AKR, and ODX

Should you buy Tristel stock or one of its competitors? MarketBeat compares Tristel with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tristel include Advanced Medical Solutions Group (AMS), INSPECS Group (SPEC), BATM Advanced Communications (BVC), Akers Biosciences (AKR), and Omega Diagnostics Group (ODX).

How does Tristel compare to Advanced Medical Solutions Group?

Tristel (LON:TSTL) and Advanced Medical Solutions Group (LON:AMS) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

21.6% of Tristel shares are owned by institutional investors. Comparatively, 22.9% of Advanced Medical Solutions Group shares are owned by institutional investors. 21.0% of Tristel shares are owned by company insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Tristel has a net margin of 15.88% compared to Advanced Medical Solutions Group's net margin of 4.35%. Tristel's return on equity of 23.64% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tristel	15.88%	23.64%	9.89%
Advanced Medical Solutions Group	4.35%	3.87%	2.35%

Advanced Medical Solutions Group has a consensus price target of GBX 270.25, indicating a potential downside of 3.65%. Given Advanced Medical Solutions Group's stronger consensus rating and higher probable upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tristel	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Advanced Medical Solutions Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Tristel had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for Tristel and 1 mentions for Advanced Medical Solutions Group. Tristel's average media sentiment score of 0.80 beat Advanced Medical Solutions Group's score of 0.44 indicating that Tristel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tristel	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Advanced Medical Solutions Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tristel has a beta of 0.339, suggesting that its share price is 66% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.701, suggesting that its share price is 30% less volatile than the broader market.

Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.3%. Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tristel	£49.54M	4.13	£6.54M	£16.24	26.23
Advanced Medical Solutions Group	£228.94M	2.66	£11.22M	£4.52	62.06

Summary

Tristel and Advanced Medical Solutions Group tied by winning 9 of the 18 factors compared between the two stocks.

How does Tristel compare to INSPECS Group?

Tristel (LON:TSTL) and INSPECS Group (LON:SPEC) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

INSPECS Group has a consensus price target of GBX 60, indicating a potential downside of 38.14%. Given INSPECS Group's stronger consensus rating and higher probable upside, analysts clearly believe INSPECS Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tristel	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
INSPECS Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Tristel had 2 more articles in the media than INSPECS Group. MarketBeat recorded 2 mentions for Tristel and 0 mentions for INSPECS Group. Tristel's average media sentiment score of 0.80 beat INSPECS Group's score of 0.00 indicating that Tristel is being referred to more favorably in the media.

Company	Overall Sentiment
Tristel	Positive
INSPECS Group	Neutral

21.6% of Tristel shares are held by institutional investors. Comparatively, 0.4% of INSPECS Group shares are held by institutional investors. 21.0% of Tristel shares are held by insiders. Comparatively, 19.6% of INSPECS Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Tristel has a beta of 0.339, suggesting that its share price is 66% less volatile than the broader market. Comparatively, INSPECS Group has a beta of 1.607, suggesting that its share price is 61% more volatile than the broader market.

Tristel has a net margin of 15.88% compared to INSPECS Group's net margin of -2.67%. Tristel's return on equity of 23.64% beat INSPECS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tristel	15.88%	23.64%	9.89%
INSPECS Group	-2.67%	-6.07%	0.45%

Tristel has higher earnings, but lower revenue than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tristel	£49.54M	4.13	£6.54M	£16.24	26.23
INSPECS Group	£191.70M	0.55	-£4.11M	-£9.40	N/A

Summary

Tristel beats INSPECS Group on 11 of the 16 factors compared between the two stocks.

How does Tristel compare to BATM Advanced Communications?

Tristel (LON:TSTL) and BATM Advanced Communications (LON:BVC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

Tristel has a net margin of 15.88% compared to BATM Advanced Communications' net margin of -14.90%. Tristel's return on equity of 23.64% beat BATM Advanced Communications' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tristel	15.88%	23.64%	9.89%
BATM Advanced Communications	-14.90%	-22.13%	0.58%

In the previous week, Tristel had 2 more articles in the media than BATM Advanced Communications. MarketBeat recorded 2 mentions for Tristel and 0 mentions for BATM Advanced Communications. Tristel's average media sentiment score of 0.80 beat BATM Advanced Communications' score of 0.00 indicating that Tristel is being referred to more favorably in the media.

Company	Overall Sentiment
Tristel	Positive
BATM Advanced Communications	Neutral

Tristel has a beta of 0.339, suggesting that its stock price is 66% less volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, suggesting that its stock price is 25% less volatile than the broader market.

Tristel has higher earnings, but lower revenue than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tristel	£49.54M	4.13	£6.54M	£16.24	26.23
BATM Advanced Communications	£123.20M	0.34	-£278.26K	-£4.20	N/A

21.6% of Tristel shares are owned by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are owned by institutional investors. 21.0% of Tristel shares are owned by company insiders. Comparatively, 31.0% of BATM Advanced Communications shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Tristel beats BATM Advanced Communications on 10 of the 13 factors compared between the two stocks.

How does Tristel compare to Akers Biosciences?

Akers Biosciences (LON:AKR) and Tristel (LON:TSTL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

21.6% of Tristel shares are owned by institutional investors. 21.0% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tristel has higher revenue and earnings than Akers Biosciences. Akers Biosciences is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akers Biosciences	£2.32M	0.00	N/A	-£129.60	N/A
Tristel	£49.54M	4.13	£6.54M	£16.24	26.23

Tristel has a net margin of 15.88% compared to Akers Biosciences' net margin of 0.00%. Tristel's return on equity of 23.64% beat Akers Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Akers Biosciences	N/A	N/A	N/A
Tristel	15.88%	23.64%	9.89%

In the previous week, Tristel had 2 more articles in the media than Akers Biosciences. MarketBeat recorded 2 mentions for Tristel and 0 mentions for Akers Biosciences. Tristel's average media sentiment score of 0.80 beat Akers Biosciences' score of 0.00 indicating that Tristel is being referred to more favorably in the news media.

Company	Overall Sentiment
Akers Biosciences	Neutral
Tristel	Positive

Summary

Tristel beats Akers Biosciences on 10 of the 10 factors compared between the two stocks.

How does Tristel compare to Omega Diagnostics Group?

Omega Diagnostics Group (LON:ODX) and Tristel (LON:TSTL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

Omega Diagnostics Group has a beta of 3.85, indicating that its share price is 285% more volatile than the broader market. Comparatively, Tristel has a beta of 0.339, indicating that its share price is 66% less volatile than the broader market.

29.8% of Omega Diagnostics Group shares are owned by institutional investors. Comparatively, 21.6% of Tristel shares are owned by institutional investors. 50.6% of Omega Diagnostics Group shares are owned by company insiders. Comparatively, 21.0% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Tristel has a net margin of 15.88% compared to Omega Diagnostics Group's net margin of -51.15%. Tristel's return on equity of 23.64% beat Omega Diagnostics Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omega Diagnostics Group	-51.15%	-29.14%	-10.53%
Tristel	15.88%	23.64%	9.89%

In the previous week, Tristel had 2 more articles in the media than Omega Diagnostics Group. MarketBeat recorded 2 mentions for Tristel and 0 mentions for Omega Diagnostics Group. Tristel's average media sentiment score of 0.80 beat Omega Diagnostics Group's score of 0.00 indicating that Tristel is being referred to more favorably in the news media.

Company	Overall Sentiment
Omega Diagnostics Group	Neutral
Tristel	Positive

Tristel has higher revenue and earnings than Omega Diagnostics Group. Omega Diagnostics Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omega Diagnostics Group	£7.55M	0.00	-£3.17M	-£0.01	N/A
Tristel	£49.54M	4.13	£6.54M	£16.24	26.23

Summary

Tristel beats Omega Diagnostics Group on 9 of the 12 factors compared between the two stocks.

Get Tristel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TSTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TSTL vs. The Competition

Export

Metric	Tristel	Healthcare Equipment & Supplies Industry	Healthcare Sector	LON Exchange
Market Cap	£204.47M	£5.64B	£7.16B	£2.79B
Dividend Yield	3.30%	1.79%	2.59%	6.15%
P/E Ratio	26.23	23.11	282.25	368.29
Price / Sales	4.13	56.83	591.88	83,501.30
Price / Cash	20.96	32.53	28.60	27.89
Price / Book	6.23	6.29	10.93	7.04
Net Income	£6.54M	£151.98M	£3.50B	£5.89B
7 Day Performance	3.40%	1.01%	-0.64%	6.05%
1 Month Performance	6.86%	4.43%	-3.78%	-0.22%
1 Year Performance	16.71%	2.35%	61.99%	63.72%

Tristel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TSTL Tristel	N/A	GBX 426 flat	N/A	+16.7%	£204.47M	£49.54M	26.23	208
AMS Advanced Medical Solutions Group	1.0947 of 5 stars	GBX 280.04 +0.0%	GBX 270.25 -3.5%	+39.6%	£608.77M	£228.94M	61.96	10
SPEC INSPECS Group	N/A	GBX 96.80 -0.2%	GBX 60 -38.0%	+131.0%	£105.68M	£191.70M	N/A	1,673	Gap Down
BVC BATM Advanced Communications	N/A	GBX 12.97 +4.2%	N/A	-26.3%	£44.11M	£123.20M	N/A	980	Gap Up
AKR Akers Biosciences	N/A	N/A	N/A	N/A	£21.64M	£2.32M	N/A	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:TSTL) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tristel (TSTL) Competitors

TSTL vs. AMS, SPEC, BVC, AKR, and ODX

How does Tristel compare to Advanced Medical Solutions Group?

Summary

How does Tristel compare to INSPECS Group?

Summary

How does Tristel compare to BATM Advanced Communications?

Summary

How does Tristel compare to Akers Biosciences?

Summary

How does Tristel compare to Omega Diagnostics Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TSTL vs. The Competition

Tristel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tristel (TSTL) Competitors

TSTL vs. AMS, SPEC, BVC, AKR, and ODX

How does Tristel compare to Advanced Medical Solutions Group?

Do insiders & institutionals believe in TSTL or AMS?

Is TSTL or AMS more profitable?

Do analysts prefer TSTL or AMS?

Does the media prefer TSTL or AMS?

Which has more volatility & risk, TSTL or AMS?

Is TSTL or AMS a better dividend stock?

Which has higher earnings and valuation, TSTL or AMS?

Summary

How does Tristel compare to INSPECS Group?

Do analysts prefer TSTL or SPEC?

Does the media prefer TSTL or SPEC?

Do insiders & institutionals believe in TSTL or SPEC?

Which has more volatility & risk, TSTL or SPEC?

Is TSTL or SPEC more profitable?

Which has higher earnings & valuation, TSTL or SPEC?

Summary

How does Tristel compare to BATM Advanced Communications?

Is TSTL or BVC more profitable?

Does the media prefer TSTL or BVC?

Which has more risk & volatility, TSTL or BVC?

Which has better valuation & earnings, TSTL or BVC?

Do insiders & institutionals hold more shares of TSTL or BVC?

Summary

How does Tristel compare to Akers Biosciences?

Do insiders and institutionals have more ownership in AKR or TSTL?

Which has stronger earnings & valuation, AKR or TSTL?

Is AKR or TSTL more profitable?

Does the media prefer AKR or TSTL?

Summary

How does Tristel compare to Omega Diagnostics Group?

Which has more volatility and risk, ODX or TSTL?

Do insiders and institutionals hold more shares of ODX or TSTL?

Is ODX or TSTL more profitable?

Does the media refer more to ODX or TSTL?

Which has stronger valuation & earnings, ODX or TSTL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TSTL vs. The Competition

Tristel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools